Protagonist Therapeutics

PTGXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$9.439 B

$145.87 -0.21%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$130.1M

Loss-making

Shares outstanding

64,708,285

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#37Praxis Precision MedicinesPRAX$10.1B
#38CytokineticsCYTK$9.55B
#39Protagonist TherapeuticsPTGX$9.44B
#40Ionis PharmaceuticalsIONS$9.40B
#41Spyre TherapeuticsSYRE$9.25B

Where these numbers come from

Share counts and financials for Protagonist Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.